Research
Energy balance
Activation of PPARα by omega-3 fatty acids (EPA/DHA) or synthetic fibrates increases fatty acid oxidation in metabolically active tissues (liver, heart, skeletal muscle), thereby lowering lipid levels and preventing hepatic steatosis.
To leverage PPARα for fat loss, focus on consuming omega-3 fatty acids (EPA/DHA) or prescribed fibrates. These compounds activate receptors that increase fatty acid oxidation in the liver and muscles, helping to clear lipids and prevent fat storage in the liver.
GoodSupportsHIGH confidence
PPARα mainly influences fatty acid metabolism and its activation lowers lipid levels... If the concentration of fatty acids increases, PPARα is activated and uptakes oxidized forms of these acids... This activation and increased PPARα sensing in the liver result in increased energy burning and reduced fat storage.
Why this rating
The paper is a comprehensive review citing multiple animal models and clinical studies on fibrates and omega-3s.
Source
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
Bogna Grygiel‐Górniak · Nutrition Journal · 2014
DOI 10.1186/1475-2891-13-17
narrative_reviewCited 1,191×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Activation of PPARγ by synthetic thiazolidinediones (glitazones) improves insulin sensitivity and reduces blood glucose in type 2 diabetes, but carries significant cardiovascular risks (e.g., rosiglitazone) and side effects (weight gain, edema).Good
- Activation of PPARβ/δ promotes fatty acid oxidation in skeletal and cardiac muscles, preventing obesity and protecting the heart from ischemia-reperfusion injury, particularly in the context of high-fat diets.Moderate
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →